262 related articles for article (PubMed ID: 24916899)
21. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in-vitro glucuronidation of arctigenin.
Xin H; Xia YL; Hou J; Wang P; He W; Yang L; Ge GB; Xu W
J Pharm Pharmacol; 2015 Dec; 67(12):1673-81. PubMed ID: 26407805
[TBL] [Abstract][Full Text] [Related]
22. Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.
Mutlib AE; Goosen TC; Bauman JN; Williams JA; Kulkarni S; Kostrubsky S
Chem Res Toxicol; 2006 May; 19(5):701-9. PubMed ID: 16696573
[TBL] [Abstract][Full Text] [Related]
23. New Insights into SN-38 Glucuronidation: Evidence for the Important Role of UDP Glucuronosyltransferase 1A9.
Xiao L; Zhu L; Li W; Li C; Cao Y; Ge G; Sun X
Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):424-428. PubMed ID: 29076612
[TBL] [Abstract][Full Text] [Related]
24. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.
Hanioka N; Naito T; Narimatsu S
Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428
[TBL] [Abstract][Full Text] [Related]
25. Glucuronidation of anticancer prodrug PR-104A: species differences, identification of human UDP-glucuronosyltransferases, and implications for therapy.
Gu Y; Tingle MD; Wilson WR
J Pharmacol Exp Ther; 2011 Jun; 337(3):692-702. PubMed ID: 21427202
[TBL] [Abstract][Full Text] [Related]
26. [Study on metabolic dynamics,metabolic enzyme phenotype and species difference of hepatic and intestinal microsome of psoralidin].
Qin ZF; Zhang BB; Xing H; Wang PL; Yang J; Zhang XJ; Yao ZH; Yao XS
Zhongguo Zhong Yao Za Zhi; 2021 Jul; 46(13):3410-3421. PubMed ID: 34396762
[TBL] [Abstract][Full Text] [Related]
27. Glucuronidation of capsaicin by liver microsomes and expressed UGT enzymes: reaction kinetics, contribution of individual enzymes and marked species differences.
Sun H; Wang H; Liu H; Zhang X; Wu B
Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1325-36. PubMed ID: 25219630
[TBL] [Abstract][Full Text] [Related]
28. N-glucuronidation of perfluorooctanesulfonamide by human, rat, dog, and monkey liver microsomes and by expressed rat and human UDP-glucuronosyltransferases.
Xu L; Krenitsky DM; Seacat AM; Butenhoff JL; Tephly TR; Anders MW
Drug Metab Dispos; 2006 Aug; 34(8):1406-10. PubMed ID: 16720684
[TBL] [Abstract][Full Text] [Related]
29. UDP-glucuronosyltransferase 1A6 is the major isozyme responsible for protocatechuic aldehyde glucuronidation in human liver microsomes.
Liu HX; Liu Y; Zhang JW; Li W; Liu HT; Yang L
Drug Metab Dispos; 2008 Aug; 36(8):1562-9. PubMed ID: 18474676
[TBL] [Abstract][Full Text] [Related]
30. Highly selective N-glucuronidation of four piperazine-containing drugs by UDP-glucuronosyltransferase 2B10.
Lu D; Dong D; Wu B
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):989-998. PubMed ID: 30049229
[TBL] [Abstract][Full Text] [Related]
31. UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin.
Fujiwara R; Sumida K; Kutsuno Y; Sakamoto M; Itoh T
Drug Metab Pharmacokinet; 2015 Feb; 30(1):82-8. PubMed ID: 25760534
[TBL] [Abstract][Full Text] [Related]
32. Regioselective glucuronidation of andrographolide and its major derivatives: metabolite identification, isozyme contribution, and species differences.
Tian X; Liang S; Wang C; Wu B; Ge G; Deng S; Liu K; Yang L; Ma X
AAPS J; 2015 Jan; 17(1):156-66. PubMed ID: 25204783
[TBL] [Abstract][Full Text] [Related]
33. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
[TBL] [Abstract][Full Text] [Related]
34. In vitro characterization of the glucuronidation pathways of licochalcone A mediated by human UDP-glucuronosyltransferases.
Xia YL; Dou TY; Lv X; Ge GB
Xenobiotica; 2019 Jun; 49(6):671-677. PubMed ID: 30044687
[TBL] [Abstract][Full Text] [Related]
35. Species difference in glucuronidation formation kinetics with a selective mTOR inhibitor.
Berry LM; Liu J; Colletti A; Krolikowski P; Zhao Z; Teffera Y
Drug Metab Dispos; 2014 Apr; 42(4):707-17. PubMed ID: 24423753
[TBL] [Abstract][Full Text] [Related]
36. In Vitro Glucuronidation of Wushanicaritin by Liver Microsomes, Intestine Microsomes and Expressed Human UDP-Glucuronosyltransferase Enzymes.
Hong X; Zheng Y; Qin Z; Wu B; Dai Y; Gao H; Yao Z; Gonzalez FJ; Yao X
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28925930
[TBL] [Abstract][Full Text] [Related]
37. Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution.
Kato Y; Nakajima M; Oda S; Fukami T; Yokoi T
Drug Metab Dispos; 2012 Feb; 40(2):240-8. PubMed ID: 22028316
[TBL] [Abstract][Full Text] [Related]
38. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.
Sun H; Zhang T; Wu Z; Wu B
J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of bergenin.
Song H; Wang J; Zhang R; Liu X; Yuan G; Wei C; Wang B; Guo R
Biomed Chromatogr; 2014 Mar; 28(3):348-53. PubMed ID: 23996546
[TBL] [Abstract][Full Text] [Related]
40. In vitro characterisation of human renal and hepatic frusemide glucuronidation and identification of the UDP-glucuronosyltransferase enzymes involved in this pathway.
Kerdpin O; Knights KM; Elliot DJ; Miners JO
Biochem Pharmacol; 2008 Jul; 76(2):249-57. PubMed ID: 18541222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
